Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Myeloproliferative Disorders × Bortezomib × Clear all

Phase

Phase 1 2 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Multiple Myeloma 4 Renal Insufficiency 1 Primary Myelofibrosis 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia 1 Breast Neoplasms 1

Interventions

Pemetrexed 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00437086 2014-10-17

Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders

Mayo Clinic

Phase EARLY_PHASE1 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡